Skip to main content
Clinical Trials/NCT00899522
NCT00899522CompletedNot Applicable

Fanconi Anemia Cancer Cell Repository

OHSU Knight Cancer Institute1 site in 1 country8 target enrollmentStarted: August 2005Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
8
Locations
1
Primary Endpoint
Creation of a Fanconi Anemia Cell Repository using rare solid tumor samples from patients with Fanconi anemia

Study Overview

Brief Summary

RATIONALE: Collecting and storing samples of tumor tissue from patients with Fanconi anemia to test in the laboratory may help the study of cancer in the future.

PURPOSE: This laboratory study is collecting and storing tumor tissue samples from patients with Fanconi anemia.

Detailed Description

OBJECTIVES:

  • Acquire rare solid tumor samples from patients with Fanconi anemia in order to create a Fanconi Anemia Cell Repository at the Oregon Health and Science University Cancer Institute.
  • Study repository tissue using a variety of molecular methods, including gene microarrays.
  • Develop cancer cell lines that are publicly available from tissue archived from patients with Fanconi anemia.

OUTLINE: Tumor biopsies are collected from patients with Fanconi anemia and archived for future molecular studies, cell line generation, and general usage by the research community at large. Medical information about the patient's cancer is also archived.

PROJECTED ACCRUAL: Not specified.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Retrospective

Eligibility Criteria

Ages
1 Year to 55 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Creation of a Fanconi Anemia Cell Repository using rare solid tumor samples from patients with Fanconi anemia

Time Frame: Duration of the study

Study tissue samples by molecular methods, including gene microarrays

Time Frame: Duration of the study

Development of cancer cell lines from tissue archived from patients with Fanconi anemia

Time Frame: Duration of the study

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Grover Bagby

Professor Emeritus

OHSU Knight Cancer Institute

Study Sites (1)

Loading locations...

Similar Trials

Tissue Sample Collection From Patients... | Clinical Trial